Bioengineering & Translational Medicine

Papers
(The H4-Index of Bioengineering & Translational Medicine is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Simultaneous detection of sepsis host response biomarkers in whole blood using electrochemical biosensor231
Polymorphic nanobody crystals as long‐acting intravitreal therapy for wet age‐related macular degeneration178
Correction to “Self‐assembly of PEGPPS polymers and LL‐37 peptide nanomicelles improves the oxidative microenvironment and promotes angiogenesis to facilitate chronic177
Engineering human skin model innervated with itch sensory neuron‐like cells differentiated from induced pluripotent stem cells117
Liver‐tumor mimics as a potential translational framework for planning and testing irreversible electroporation with multiple electrodes88
Insights into the mechanisms, regulation, and therapeutic implications of extracellular matrix stiffness in cancer87
Advanced strategies to thwart foreign body response to implantable devices81
miRNA‐encapsulated abiotic materials and biovectors for cutaneous and oral wound healing: Biogenesis, mechanisms, and delivery nanocarriers78
Evaluation of the efficacy and safety of ionic liquids containing ketoconazole in patients with tinea pedis: A randomized controlled clinical trial74
Fortifying angiogenic efficacy of conditioned media using phototoxic‐free blue light for wound healing69
Novel metal peroxide nanoboxes restrain Clostridioides difficile infection beyond the bactericidal and sporicidal activity67
A high‐throughput microfluidic mechanoporation platform to enable intracellular delivery of cyclic peptides in cell‐based assays61
Introduction to Editorial Board Member: Professor Jennifer L. West60
A soft, bioinspired artificial lymphatic system for interactive ascites transfer58
4D‐CT deformable image registration using unsupervised recursive cascaded full‐resolution residual networks57
Stirred culture of cartilaginous microtissues promotes chondrogenic hypertrophy through exposure to intermittent shear stress52
Light controlled self‐escape capability of non‐cationic carbon nitride‐based nanosheets in lysosomes for  hepatocellular carcinoma targeting stimulus‐responsive gene delivery50
A polymer‐based systemic hemostat for managing uncontrolled bleeding47
Formulation‐based approaches for dermal delivery of vaccines and therapeutic nucleic acids: Recent advances and future perspectives47
E3 ligase activity of Carboxyl terminus of Hsc70 interacting protein (CHIP) in Wharton's jelly derived mesenchymal stem cells improves their persistence under hyperglycemic stres44
Biomimetic nanotherapeutics for targeted drug delivery to glioblastoma multiforme43
Customized flexible hollow microneedles for psoriasis treatment with reduced‐dose drug40
Mitomycin C‐immobilized silver nanoparticle‐loaded polycaprolactone membrane for temporary scalp expansion after decompressive craniectomy to prevent wound infection39
Clathrin light chain‐conjugated drug delivery for cancer38
Soluble CD80 oral delivery by recombinant Lactococcus suppresses tumor growth by enhancing antitumor immunity34
Matrix metalloproteinase 2‐responsive dual‐drug‐loaded self‐assembling peptides suppress tumor growth and enhance breast cancer therapy34
Deep learning‐based multimodal fusion network for segmentation and classification of breast cancers using B‐mode and elastography ultrasound images33
BioTM Buzz (Volume 6, Issue 2)32
Tracking metabolic responses based on macronutrient consumption: A comprehensive study to continuously monitor and quantify dual markers (cortisol and glucose) in human sweat using WATCH se32
Biomedical applications of three‐dimensional bioprinted craniofacial tissue engineering32
Green/red fluorescent protein disrupting drugs for real‐time permeability tracking in three‐dimensional tumor spheroids32
Ultrasound‐guided interstitial photothermal therapy generates improved treatment responses in a 9464D model of neuroblastoma31
An ultralow power wearable vital sign sensor using an electromagnetically reactive near field31
0.1050009727478